Strawberry Candy Twists as an Alternative Screen for Gestational Diabetes: A Prospective Trial
Launched by BAYLOR COLLEGE OF MEDICINE · Nov 18, 2015
Trial Information
Current as of July 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is exploring whether eating 10 Twizzlers (a type of strawberry candy) could be a better way to screen for gestational diabetes than the standard drink used in testing, which is a sugary beverage called glucola. Gestational diabetes is a condition that can occur during pregnancy and can affect both the mother and the baby. The study is looking for pregnant women who are between 24 to 28 weeks along in their pregnancy, whether they are having one baby, twins, or triplets. Unfortunately, women who have diabetes, are on certain medications, or who have had a previous high glucose test result won't be able to participate.
If you are eligible and choose to join the study, you will be asked to eat the Twizzlers and then have your blood tested to see how your body handles the sugar. This could help researchers find a more enjoyable and effective way to screen for gestational diabetes. The trial is currently recruiting participants, so if you know someone who might be interested and meets the criteria, this could be a great opportunity to help improve prenatal care!
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Pregnant
- • 24 to 28 weeks gestation
- • Singleton or twin or triplet gestation
- • Willing to participate in the study
- Exclusion Criteria:
- • Known Type II DM
- • Known Type I DM
- • On oral or injectable corticosteroids
- • 50 gram glucola beverage GCT of greater than or equal to 190 mg/dl
About Baylor College Of Medicine
Baylor College of Medicine is a leading academic institution dedicated to advancing health through innovative research, education, and clinical care. Located in Houston, Texas, it is renowned for its commitment to excellence in medical education and translational research, fostering collaborations that bridge laboratory discoveries with clinical application. As a clinical trial sponsor, Baylor College of Medicine leverages its robust infrastructure, interdisciplinary expertise, and access to diverse patient populations to conduct cutting-edge clinical studies aimed at improving patient outcomes and enhancing therapeutic approaches across a wide range of medical conditions.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Houston, Texas, United States
Patients applied
Trial Officials
Kjersti Aagaard, MD, PhD
Principal Investigator
Baylor College of Medicine
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials